Principal Financial Group Inc Aspira Women'S Health Inc. Transaction History

Principal Financial Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.4 - $1.09 $5,677 - $15,471	-14,194 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$0.88 - $1.81 $1,670 - $3,435	1,898 Added 15.44%	14,194 $15,000
Q4 2021 Feb 09, 2022	SELL	$1.63 - $3.43 $5,550 - $11,679	-3,405 Reduced 21.69%	12,296 $22,000
Q3 2021 Nov 09, 2021	BUY	$3.19 - $5.48 $13,005 - $22,341	4,077 Added 35.07%	15,701 $51,000
Q2 2021 Aug 10, 2021	SELL	$4.78 - $6.84 $25,936 - $37,113	-5,426 Reduced 31.82%	11,624 $65,000
Q1 2021 May 10, 2021	SELL	$5.9 - $9.13 $15,623 - $24,176	-2,648 Reduced 13.44%	17,050 $115,000
Q4 2020 Feb 08, 2021	BUY	$3.0 - $6.71 $24,204 - $54,136	8,068 Added 69.37%	19,698 $132,000
Q3 2020 Nov 06, 2020	BUY	$2.54 - $4.56 $29,540 - $53,032	11,630 New	11,630 $35,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.